Visits: 1506, Avg visit time (secs): 310,59 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 791 | 52,52% | |
| /amylin/efsd-amylin-rfa08.html | 144 | 9,56% |
| /programmes.html | 118 | 7,84% |
| /msd/albert-renold/efsd-msd-arenold.html | 57 | 3,78% |
| /pfizer/efsd-pfizer-rfa08.html | 36 | 2,39% |
| /lifescan/efsd-lifescan-rfa08.html | 29 | 1,93% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 29 | 1,93% |
| /novartis/efsd-novartis-rfa08.html | 19 | 1,26% |
| /home.html | 17 | 1,13% |
| /gsk/efsd-gsk-rfa08.html | 17 | 1,13% |
| /regulations.html | 13 | 0,86% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 926 | 61,49% |
| /msd/albert-renold/efsd-msd-arenold.html | 64 | 4,25% |
| /home.html | 44 | 2,92% |
| /amylin/efsd-amylin-rfa08.html | 38 | 2,52% |
| /efsd-grant/efsd-clinresgrant-rfa07.html | 33 | 2,19% |
| /lifescan/efsd-lifescan-rfa08.html | 29 | 1,93% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 28 | 1,86% |
| /recipients.html | 24 | 1,59% |
| /programmes.html | 17 | 1,13% |
| /pfizer/efsd-pfizer-rfa08.html | 16 | 1,06% |
| /lilly/fellowships/efsd-lilly-fship08.html | 15 | 1,00% |